Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home

Last updated: June 9, 2021
Sponsor: Universidad Complutense de Madrid
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04922918
CEIC 20/263-E_COVID
  • Ages 74-98
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The objective of this work was to investigate the effect of Ligilactobacillus salivarius MP101 on the functional (Barthel index), cognitive (GDS/FAST) and nutritional (MNA) status, and on the nasal and fecal inflammatory profiles of elderly living in a nursing home highly affected by COVID-19.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Living in the nursing home
  • Informed consent obtained

Exclusion

Exclusion Criteria:

  • Absence of informed consent
  • Parenteral nutrition (exclusively)
  • Allergy to cow's milk protein

Study Design

Total Participants: 25
Study Start date:
October 01, 2020
Estimated Completion Date:
July 01, 2021

Connect with a study center

  • Centro Para Mayores Santa Isabel, S.L.

    Moralzarzal, Madrid 28411
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.